'Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis Persists After Immunotherapy Cessation’ by Braaten Et Al: Another Point of View

Annals of the Rheumatic Diseases - United Kingdom
doi 10.1136/annrheumdis-2019-216867
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Immune Checkpoint Inhibitor-Induced Fanconi Syndrome

Cureus
2020English

Another Point of View

Science
MultidisciplinaryPhilosophy of ScienceHistory
2019English

Response to Comment on Trinh Et Al. Successful Treatment of Immune Checkpoint Inhibitor–Induced Diabetes With Infliximab. Diabetes Care 2019;42:e153–e154

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2019English

Characteristics and Treatment of New-Onset Arthritis After Checkpoint Inhibitor Therapy

RMD Open
RheumatologyAllergyImmunology
2018English

Tenosynovitis Induced by an Immune Checkpoint Inhibitor: A Case Report and Literature Review

Internal Medicine
Internal MedicineMedicine
2019English

Immune Checkpoint Inhibitor Nephrotoxicity: Update 2020

Kidney360
2020English

In Reply — Immune Checkpoint Inhibitor–Induced Type 1 Diabetes: An Underestimated Risk

Mayo Clinic Proceedings
Medicine
2020English

Loss of Fas Expression and Function Is Coupled With Colon Cancer Resistance to Immune Checkpoint Inhibitor Immunotherapy

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2018English

Systemic Immunotherapy of Superficial Mouse Bladder Cancer With Avelumab (MSB0010718C), an Anti-Pd-L1 Immune Checkpoint Inhibitor

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy